Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
Top Cited Papers
Open Access
- 16 June 2021
- journal article
- review article
- Published by BMJ in BMJ Neurology Open
- Vol. 3 (1) , e000143
Abstract
Objective: To assess the overall pooled correlation coefficient estimate between cerebrospinal fluid (CSF) and blood neurofilament light (NfL) protein. Methods: We searched Medline, Embase and Web of Science for published articles, from their inception to 9 July 2019, according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Studies reporting the correlation between CSF and blood NfL in humans were included. We conducted a random-effects meta-analysis to calculate the overall pooled correlation coefficient estimate, accounting for correlation technique and assay used. Heterogeneity was assessed using the I2 statistic test. In sensitivity analyses, we calculated the pooled correlation coefficient estimate according to blood NfL assay: single-molecule array digital immunoassay (Simoa), electrochemiluminescence (ECL) assay or ELISA. Results: Data were extracted from 36 articles, including 3961 paired CSF and blood NfL samples. Overall, 26/36 studies measured blood NfL using Simoa, 8/36 ECL, 1/36 ELISA and 1 study reported all three assay results. The overall meta-analysis demonstrated that the pooled correlation coefficient estimate for CSF and blood NfL was r=0.72. Heterogeneity was significant: I2=83%, p<0.01. In sensitivity analyses, the pooled correlation coefficient was similar for studies measuring blood NfL using Simoa and ECL (r=0.69 and r=0.68, respectively) but weaker for ELISA (r=0.35). Conclusion: Moderate correlations are demonstrated between CSF and blood NfL, especially when blood NfL was measured using Simoa and ECL. Given its high analytical sensitivity, Simoa is the preferred assay for measuring NfL, especially at low or physiological concentrations, and this meta-analysis supports its use as the current most advanced surrogate measure of CSF NfL. PROSPERO registration number: CRD42019140469Keywords
This publication has 59 references indexed in Scilit:
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosisAnnals of Neurology, 2015
- Neurofilament light chainNeurology, 2015
- CSF neurofilament light chain reflects corticospinal tract degeneration in ALSAnnals of Clinical and Translational Neurology, 2015
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesPLOS ONE, 2013
- A comparative study of CSF neurofilament light and heavy chain protein in MSMultiple Sclerosis Journal, 2013
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian DisordersArchives of Neurology, 2012
- Neurofilaments as biomarkers in multiple sclerosisMultiple Sclerosis Journal, 2012
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviewsSystematic Reviews, 2012
- Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSFJournal of Neurochemistry, 1996